A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide, largely due to its high rate of recurrence after surgery. Even after complete tumor removal, microscopic ...

Differentiating tunnel and abscess/inflammatory nodule recurrence refines surgical outcomes after wide excision in patients ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive ...

Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed no differences in recurrence after endoscopic local resection of low- or high-risk CRC ...

Ductal carcinoma in situ (DCIS) is a low-risk form of early-stage breast cancer. Women with DCIS can have radiation after the tumor is removed to lower the risk that the cancer could come back. A new ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...